ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,048.07
0.25%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Psychemedics Corporation (PMD)

  7. Psychemedics Corporation (PMD) ニュース

PMD Psychemedics Corporation

2.55
-0.0863 (-3.27%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Psychemedics Corporation PMD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.0863 -3.27% 2.55 13:00:01
始値 安値 高値 終値 前日終値
2.64 2.53 2.64 2.55 2.6363
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2821:20GLOBEPsychemedics Corporation Reports 2023 Financial Results
2024/3/2122:00GLOBEPsychemedics Recognized as a Top 10 Employee Health Testing..
2024/2/1323:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0306:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2706:10EDGAR2Form 8-K - Current report
2024/1/2507:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0301:27GLOBEPsychemedics Corporation Announces Relocation of..
2023/12/2006:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/1502:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/2801:31EDGAR2Form 8-K - Current report
2023/11/2723:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
2023/11/1407:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1007:00GLOBEPsychemedics Corporation Reports Third Quarter 2023..
2023/11/1007:00EDGAR2Form 8-K - Current report
2023/11/0907:00EDGAR2Form 8-K - Current report
2023/10/2800:00GLOBEUnveiling the Future of Drug Testing: Psychemedics..
2023/9/2607:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2302:00EDGAR2Form 8-K - Current report
2023/9/2206:00GLOBEPsychemedics Corporation Appoints Shannon Shoemaker as Chief..
2023/9/0106:20EDGAR2Form 8-K - Current report
2023/8/2306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2306:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/2206:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2206:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2206:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2206:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2206:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2206:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2206:01EDGAR2Form 8-K - Current report
2023/8/1903:00GLOBEPsychemedics Corporation Reports Inducement Grants Under..
2023/8/1806:30EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1506:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1206:10GLOBEPsychemedics Corporation Reports Second Quarter 2023..
2023/8/1206:10EDGAR2Form 8-K - Current report
2023/7/2206:00EDGAR2Form 8-K - Current report
2023/7/2205:00EDGAR2Form DEF 14A - Other definitive proxy statements
2023/7/1422:15EDGAR2Form 8-K - Current report
2023/7/1306:15GLOBEPsychemedics Corporation Announces CEO Succession Plan
2023/5/1006:30GLOBEPsychemedics Corporation Reports First Quarter 2023..

最近閲覧した銘柄

NASDAQ
PMD
Psychemedics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有